NRC International Partners (Regional), Day 3, Track 2, 11:00-12:30

Presented as part of the Uniting the global community to face the challenge of addiction event, in-person on 14th May, 2022

Presentations:

• Novel Therapeutic Interventions for Psychostimulant Use Disorders and Overdose - Ivan Montoya, M.D., M.P.H.
• The Role of Fund for Drug Control and Treatment of Addiction (FDCTA) in drug demand reduction in Egypt 2015-2021 - Dr. Amr Osman
• Addiction treatment Services Development - Dr. Raghdah Algamil

Abstracts:

• Novel Therapeutic Interventions for Psychostimulant Use Disorders and Overdose - Ivan Montoya, M.D., M.P.H.

The popularity of psychostimulant use appears rebounding in many countries. The prevalence of Psychostimulant (cocaine and methamphetamine) Use Disorders (PsUD) and deaths associated with psychostimulant overdose (PsOD) have been increasing in recent years. In the United States, the age-adjusted mortality rate per 100,000 due to PsOD increased from 0.2 in 1999 to 7.5 in 2020. In other words, 23,837 individuals died because of PsOD in 2020. Moreover, it has been reported that in 2020 there were 1.3 and 1.5 million people with cocaine and methamphetamine use disorder, respectively. It has also been reported that 603,000 and 635,000 individuals received treatment for cocaine and methamphetamine use disorder, respectively. Despite these alarming numbers, there are no medications approved by the FDA to treat PsUD and PsOD. Because of the resurgence of these conditions, the National Institute on Drug Abuse of the United States has increased the support of research to discover and develop new approaches to treat them. They include the evaluation of the safety and efficacy of new molecular entities, repurposed medications, biologics (vaccines, monoclonal antibodies and enzymes), as well as non-pharmacological interventions such as therapeutic devices, digital interventions, and behavioral therapies. The purpose of the presentation is to provide an overview of the advances in the research supported by NIDA to treat PsUD and PsOD. It is expected that at the end of the presentation, participants will become familiar with the most promising therapeutic interventions in the research pipeline for PsUD and PsOD.

• The Role of Fund for Drug Control and Treatment of Addiction (FDCTA) in drug demand reduction in Egypt 2015-2021 - Dr. Amr Osman

This presentation gives insight into the recent and current Best Practices of Egypt's Experience in Countering Drugs Problem, From Prevention to Recovery, through its main national mechanism of drug demand reduction; (FDCTA). FDCTA’s work is concentered on many topics in dealing with drug abuse problem in Egypt. As FDCTA strives to create a healthy, drug-free society, whose members have awareness, knowledge and life skills that enable them to face the temptations and dangers of drugs through its scientific evidence-based preventive programmes. FDCTA provides free and confidential high-quality treatment services available fairly with no discrimination to victims of drug abuse disorders. Special emphasis was given to develop different components of treatment, rehabilitation and reintegration services; that comply with both human rights and good clinical practices, considering UNODC’s criteria as the main guideline in that matter. FDCTA has developed smart procedures to enhance sustained recovery of these Patients and to ensure their social reintegration with the community’s support. FDCTA also has developed Egyptian national policies and unique approach to tackle this problem, which is evidence based, documented and evaluated though all stages. In this presentation all the achievements of FDCTA’s experience in the last seven years are shown clearly with accurate and evidence-based data.

• Addiction treatment Services Development - Dr. Raghdah Algamil